 |
|
|
|
|
|
|
|
 |
Results for 'Animal Health Products Antibacterials Markets' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Animal Health Products Antibacterials Markets
|
May 2008 |
£1340 |
100 % |
Generics in the Animal Health Industry
|
January 2006 |
£795 |
31.15 % |
European Animal Health Markets & Opportunities
|
January 2007 |
£895 |
31.15 % |
Companion Animal Health Products: New edition
|
January 2006 |
£795 |
30.1 % |
Women's Health: Diagnostic Testing
|
August 2008 |
£1220 |
28 % |
Animal Pharm's Top Tier Companies
2007 edition
|
January 2007 |
£895 |
27.65 % |
Animal Pharm's Top 20
2006 edition
|
January 2006 |
£795 |
25.55 % |
The OTC Animal Health Global Market Opportunity
|
January 2007 |
£895 |
23.45 % |
Antiparasitics in the Animal Health Industry
2007 edition
|
January 2007 |
£895 |
21 % |
Veterinary Health Markets
|
August 2007 |
£2280 |
21 % |
Nutraceuticals
|
April 2007 |
£39.95 |
20.65 % |
Livestock Performance Products and Markets
|
January 2007 |
£895 |
19.95 % |
World Animal Health Markets
|
January 2006 |
£795 |
19.5 % |
Veterinary Pharmacy
1st Edition
|
January 2004 |
£39.95 |
18.55 % |
Enzymes
US industry forecasts to 2010 & 2015
|
July 2006 |
£2885 |
16.45 % |
Bayer HealthCare AG Product Pipeline Analysis
|
August 2008 |
£505 |
15.75 % |
Bayer Healthcare
Strategic Analysis Profile
|
February 2008 |
£530 |
15.75 % |
Developing Integrated Market Research Functions
Decision Support for 2008
|
July 2007 |
£5160 |
15.4 % |
Maximizing Your Brand Value
|
August 2007 |
£4690 |
15.4 % |
North American Animal Health Regulations (2 volumes)
|
January 2007 |
£895 |
14.35 % |
Veterinary diagnostics and equipment
The global market
|
January 2006 |
£795 |
13.65 % |
Bayer HealthCare AG Healthcare - Medical Equipment SWOT Report
|
August 2008 |
£45 |
13.65 % |
Boehringer Ingelheim GmbH Healthcare - Medical Equipment SWOT Report
|
August 2008 |
£45 |
13.65 % |
Bayer HealthCare AG Medical Equipment Company Share Analysis
|
September 2008 |
£380 |
12.95 % |
Tanabe Prospects to 2010
Pipeline, Products,Performance,Potential
|
September 2007 |
£595 |
12.5 % |
Nutraceuticals for the Animal Health Industry
|
January 2007 |
£895 |
12.5 % |
Indian Medical Market Report
2005
|
May 2005 |
£1110 |
11.9 % |
Boehringer Ingelheim GmbH Medical Equipment Company Share Analysis
|
September 2008 |
£380 |
11.55 % |
Asian Animal Health Regulations
|
January 2007 |
£450 |
11.2 % |
Pfizer - Market Outlook for a Global Leader, 2008-2013
|
August 2008 |
£2999 |
11.2 % |
Wyeth - SWOT Analysis
|
June 2008 |
£66 |
11 % |
Wyeth
PharmaVitae Profile
|
July 2008 |
£3010 |
10.85 % |
Wyeth: PharmaVitae Profile
PharmaVitae Profile
|
January 2007 |
£3000 |
10.85 % |
Pipeline Insight Migraine
Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries
|
November 2007 |
£3010 |
10.5 % |
Nutraceuticals and Dietary Supplements Markets
|
September 2007 |
£2280 |
10.5 % |
Global Markets for Antifungal Agents
|
March 2007 |
£3255 |
10.15 % |
Animal Biotechnology
Technologies, Markets and Companies
|
September 2008 |
£900 |
10.15 % |
The China Pharmaceutical Market: A Strategic Opportunity Analysis
|
January 2007 |
£600 |
10.15 % |
Kyowa Hakko Kogyo Co., Ltd. - SWOT Analysis
|
July 2007 |
£66 |
10 % |
Schering-Plough: PharmaVitae Profile
PharmaVitae Profile
|
September 2006 |
£3000 |
9.8 % |
Teva Pharmaceutical Industries Generics Company Intelligence Report
|
June 2008 |
£195 |
9.8 % |
Virbac Corporation - SWOT Analysis
|
February 2008 |
£66 |
9.5 % |
Nutrigenomics
Impacts on Markets, Diets, and Health
|
June 2005 |
£1950 |
9.45 % |
Medical Nanotechnology Markets
|
September 2008 |
£2280 |
9.1 % |
Boehringer Ingelheim: PharmaVitae Profile
PharmaVitae Profile
|
October 2006 |
£3000 |
9.1 % |
Wyeth Prospects to 2010
Performance, Products, Pipeline and Potential
|
July 2007 |
£595 |
9 % |
Merck & Co., Inc. - SWOT Analysis
SWOT Analysis
|
May 2008 |
£66 |
9 % |
Eli Lilly and Company - SWOT Analysis
|
September 2007 |
£125 |
9 % |
Boehringer Ingelheim GmbH - SWOT Analysis
|
June 2008 |
£66 |
8.5 % |
Naturally Healthy Kids' Food: Snacks, Breakfast and Dinner
15 Case Studies
|
December 2006 |
£145 |
8.05 % |
Tiletamine (vet): Pipeline™ Selector
Patent Report
|
Ongoing |
£210 |
8 % |
New Trends in European Pharmacy
|
January 2001 |
£200 |
7.7 % |
Schering-Plough Corporation Deals
Partneringdesk briefing
|
July 2005 |
£215 |
7.5 % |
DNA Sequencing
|
February 2008 |
£3020 |
7 % |
Contract Research and Manufacturing Services
India (CRAMS)
|
March 2008 |
£600 |
6.65 % |
Indian Biodiesel
Industry Report
|
January 2006 |
£400 |
6.3 % |
Veterinary Drug Residues & MRLs
|
January 2006 |
£795 |
6 % |
Indian Pharmaceutical Industry
|
July 2008 |
£2280 |
5.95 % |
Executive Guide to Molecular Imaging; The
|
April 2005 |
£395 |
5.6 % |
RNAi
Technologies, Markets and Companies
|
September 2008 |
£2010 |
5.6 % |
Pharmaceutical R&D Productivity
The Path to Innovation
|
October 2005 |
£1945 |
5.6 % |
Metabolomics
|
January 2008 |
£1850 |
5.6 % |
The Executive Guide to Molecular Imaging
|
July 2007 |
£595 |
5.25 % |
Diabetes Drug Discoveries
What the Future Holds
|
January 2007 |
£1495 |
4.55 % |
|
|
|
|
